These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 4284805)

  • 1. Purification of localizing antibodies formed against microsomes of the N-2-fluorenylacetamide-induced rat hepatoma.
    Isojima S; Yagi Y; Planinsek J; Pressman D
    Cancer Res; 1965 Aug; 25(7):962-7. PubMed ID: 4284805
    [No Abstract]   [Full Text] [Related]  

  • 2. Differences between antibodies against the dense sediment and microsome fractions of the N-2-fluorenylacetamide-induced rat hepatoma.
    Isojima S; Bernecky J; Planinsek J; Yagi Y; Pressman D
    Cancer Res; 1965 Aug; 25(7):968-75. PubMed ID: 4284751
    [No Abstract]   [Full Text] [Related]  

  • 3. Differences between the microsomes of normal rat liver and of N-2-fluorenylacetamide-induced rat hepatoma as determined by the paired label antibody technic.
    Isojima S; Planinsek J; Yagi Y; Pressman D
    Cancer Res; 1966 Jul; 26(7):1527-33. PubMed ID: 4287849
    [No Abstract]   [Full Text] [Related]  

  • 4. IgG associated with microsomes from autochthonous hepatomas and normal liver of rats.
    Witz I; Yagi Y; Pressman D
    Cancer Res; 1967 Dec; 27(12):2295-9. PubMed ID: 4170380
    [No Abstract]   [Full Text] [Related]  

  • 5. Increased activity of polynucleotide ligase from rat hepatoma induced by N-2-fluorenylacetamide.
    Tsukada K; Hokari S; Hayasaki N; Ito N
    Cancer Res; 1972 May; 32(5):886-8. PubMed ID: 4336027
    [No Abstract]   [Full Text] [Related]  

  • 6. Regulation of cholesterol biosynthesis in rat liver after the administration of N-2-fluorenylacetamide.
    Calandra S; Guariento D; Rivasi F
    Lab Invest; 1973 Jun; 28(6):723-7. PubMed ID: 4351645
    [No Abstract]   [Full Text] [Related]  

  • 7. Cell loss and proliferation induced by N-2-fluorenylacetamide in the rat liver in relation to hepatoma induction.
    Albert RE; Burns FJ; Bilger L; Gardner D; Troll W
    Cancer Res; 1972 Oct; 32(10):2172-7. PubMed ID: 4343011
    [No Abstract]   [Full Text] [Related]  

  • 8. LOCALIZING PROPERTIES OF ANTI-RAT HEPATOMA ANTIBODIES IN VIVO.
    KYOGOKU M; YAGI Y; PLANINSEK J; BERNECKY J; PRESSMAN D
    Cancer Res; 1964 Feb; 24():268-79. PubMed ID: 14115695
    [No Abstract]   [Full Text] [Related]  

  • 9. [On the study of specific antigens of hepatoma induced to rats by N-nitrosodiethyl-amine].
    Fel' VIa; Shvemberger IN; Ivanov VA
    Tsitologiia; 1965; 7(3):416-20. PubMed ID: 4286471
    [No Abstract]   [Full Text] [Related]  

  • 10. Rabbit antibodies to nucleoli of Novikoff hepatoma and normal liver of the rat.
    Busch RK; Daskal I; Spohn WH; Kellermayer M; Busch H
    Cancer Res; 1974 Sep; 34(9):2362-7. PubMed ID: 4367290
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of trypan blue on hepatocarcinogenesis in rats given ethionine or N-2-fluorenylacetamide.
    Ito N; Farber E
    J Natl Cancer Inst; 1966 Dec; 37(6):775-85. PubMed ID: 4289069
    [No Abstract]   [Full Text] [Related]  

  • 12. [ 131 I-labelled tumor-specific antibodies: trial to concentrate radioisotopes specifically in the tumor. I. Binding of anti-mouse hepatoma antibody to the tumor].
    Makidono R; Watanabe K; Terashima H; Matsuura K; Nomoto K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1972 Aug; 32(5):412-24. PubMed ID: 4344874
    [No Abstract]   [Full Text] [Related]  

  • 13. Cellular analysis of liver carcinogenesis. 3. Comparison of the ultrastructure of hyperplastic liver nodules and hepatocellular carcinomas induced in rat liver by 2-fluorenylacetamide.
    Merkow LP; Epstein SM; Farber E; Pardo M; Bartus B
    J Natl Cancer Inst; 1969 Jul; 43(1):33-63. PubMed ID: 4307705
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effects of specific antibodies on the ultrastructure of Yoshida ascites hepatoma in vitro].
    Marsilii G; Chiarugi V
    Folia Allergol (Roma); 1966; 13(5):366-8. PubMed ID: 4171663
    [No Abstract]   [Full Text] [Related]  

  • 15. The investigation of some antigens of Zajdela ascitic rat hepatoma cells.
    Ivanov VA; Fel VJ; Olenov JM
    Cancer Res; 1968 Aug; 28(8):1524-30. PubMed ID: 4299825
    [No Abstract]   [Full Text] [Related]  

  • 16. Metabolism of continuously fed 14C-labeled N-hydroxy-N-2-fluorenylacetamide at various intervals: effect of pituitary hormones.
    Shirasu Y; Grantham PH; Weisburger EK; Weisburger JH
    Cancer Res; 1967 May; 27(5):865-72. PubMed ID: 4290554
    [No Abstract]   [Full Text] [Related]  

  • 17. The cellular analysis of liver carcinogenesis. VI. Growth and ultrastructural characteristics of n-2-fluorenylacetamide hyperplastic liver nodule cells grown in vitro.
    Slifkin M; Merkow LP; Epstein SM; Pardo M
    Arch Pathol; 1972 Jul; 94(1):1-10. PubMed ID: 4338214
    [No Abstract]   [Full Text] [Related]  

  • 18. Demonstration and purification of a specific antigen in Morris hepatoma 5123.
    Kyriazis AP; Wissler RW
    Lab Invest; 1972 Feb; 26(2):178-83. PubMed ID: 4333964
    [No Abstract]   [Full Text] [Related]  

  • 19. Localization of radioiodinated antibody to alpha-fetoprotein in hepatoma transplanted in rats and a case report of alpha-fetoprotein antibody treatment of a hepatoma patient.
    Koji T; Ishii N; Munehisa T; Kusumoto Y; Nakamura S; Tamenishi A; Hara A; Kobayashi K; Tsukada Y; Nishi S; Hirai H
    Cancer Res; 1980 Aug; 40(8 Pt 2):3013-5. PubMed ID: 6156759
    [No Abstract]   [Full Text] [Related]  

  • 20. [Tumor lipids. Phospholipid distribution in mitochondria and microsomes of the solid rat hepatoma-27 and mouse hepatoma-22].
    Diatlovitskaia EV; Torkhovskaia TI; Sorokina IB; Gor'kova NP; Bergel'son LD
    Biokhimiia; 1970; 35(3):489-92. PubMed ID: 4319424
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.